Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBINE: Methotrexate + Anti-TNF in Pediatric Crohn's
NCT02772965Phase 3Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2016
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in Crohn's disease, sponsored by University of North Carolina at Chapel Hill. Started Oct 2016; status: completed.
02
Drugs
methotrexate
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02772965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772965.